July 17th 2025
Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
From the Editor-In-Chief: Getting to The Prestige in Cancer Care
ACOs Had No Significant Impact on Spending for Patients With Cancer
FDA Approves Libtayo to Treat Second Most Common Skin Cancer
Does Transcriptional Loss of HLA Cause Immunotherapy Resistance?